News

Urey Hall Chemists Reveal History of Two Mysterious Space Rocks

Two unusual space rocks that survived their fiery falls through Earth’s atmosphere have ended up in the Urey Hall chemistry laboratory of Mark Thiemens, whose group identified one as a new class of Martian meteorite that likely originated from the Red Planet’s crust.

January 31, 2013Science and Engineering

The Icon of Organic Chemistry

Ask any science major to name the toughest class they’ve had to complete in order to get into medical school or finish their undergraduate degree and, more than likely, the answer will be introductory organic chemistry.

January 31, 2013Science and Engineering

UC San Diego to Host Workshop on Future of Stereoscopic 3D Cinema

What exactly is stereoscopic three-dimensional (S3D) cinematography? How does it differ from other 3D filmmaking techniques? Is S3D here to stay for future theatrical experiences—or will it fall by the wayside like such forgotten technologies as Nintendo’s 1995 Virtual Boy gaming console or the Sensorama – the earliest virtual-reality “Experience Theater” patented in the 1960s?

January 28, 2013Events, General, Science and Engineering

Low Vitamin D Levels Linked to High Risk of Premenopausal Breast Cancer

A prospective study led by researchers from the University of California, San Diego School of Medicine has found that low serum vitamin D levels in the months preceding diagnosis may predict a high risk of premenopausal breast cancer.

January 24, 2013General, Health, Science and Engineering

Blocking Digestive Enzymes May Reverse Shock, Stop Multiorgan Failure

New research from the University of California, San Diego published in the Jan. 23 issue of Science Translational Medicine moves researchers closer to understanding and developing treatments for shock, sepsis and multiorgan failure. Collectively, these maladies represent a major unmet medical need: they are the number one cause of mortality in intensive care units in the United States, with hundreds of thousands of deaths annually. There is currently no treatment for these conditions in spite of many clinical trials.

January 23, 2013General, Health, Science and Engineering

Drug Targets Hard-to-Reach Leukemia Stem Cells Responsible for Relapses

Researchers at the University of California, San Diego School of Medicine have discovered that hard-to-reach, drug-resistant leukemia stem cells (LSCs) that overexpress multiple pro-survival protein forms are sensitive – and thus vulnerable – to a novel cancer stem cell-targeting drug currently under development.

January 17, 2013General, Health, Science and Engineering

How Cells Know When It’s Time to Eat Themselves

Researchers at the University of California, San Diego School of Medicine have identified a molecular mechanism regulating autophagy, a fundamental stress response used by cells to help ensure their survival in adverse conditions.

January 17, 2013General, Health, Science and Engineering

Surgical Technique Spots Cancer Invasion with Fluorescence

A team of surgeons and scientists at University of California, San Diego School of Medicine have developed a new technique that will allow surgeons to identify during surgery which lymph nodes are cancerous so that healthy tissue can be saved. The findings will be published in the January 15 print edition of Cancer Research.

January 10, 2013General, Health, Science and Engineering

Regulating Single Protein Prompts Fibroblasts to Become Neurons

Repression of a single protein in ordinary fibroblasts is sufficient to directly convert the cells into functional neurons. The findings, which could have far-reaching implications for the development of new treatments for neurodegenerative diseases like Huntington’s, Parkinson’s and Alzheimer’s, will be published online in advance of the January 17 issue of the journal Cell.

January 10, 2013General, Health, Science and Engineering

Next Steps in Potential Stem Cell Therapy for Diabetes

Researchers from the University of California, San Diego School of Medicine, collaborating with scientists from San Diego-based biotech company ViaCyte, Inc., looked at the differences and similarities between two types of hESC-derived endocrine cell populations and primary human endocrine cells, with the longer-term goal of developing new stem cell therapies for diabetes.

January 10, 2013General, Health, Science and Engineering

Previous Page   Next Page

Older stories (prior to October 2011)